Series C funding round for Affinia Therapeutics raising $40M in October 2025
Series C funding round for Affinia Therapeutics raising $40M in October 2025
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Private | — | |
| Public | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Eli Lilly | |
| Angel | Ed Mathers |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$210M
Top Valuation
-
Affinia Therapeutics raised $40M in a Series C round.
The round was announced on 10/01/25.
The round was led by New Enterprise Associates.